Drug Discovery
  • Target deconvolution
  • Target validation
  • Mode of action analysis
  • Toxicity profiling
Clinical Proteomics
  • Translational research
  • Companion diagnostics
  • Complex biomarker signatures
  • Drug response prediction
Disease and Systems Biology
  • Signal transduction
  • Disease mechanisms
  • Mechanistic biomarkers
  • Multi-omics integration
Accelerating drug and biomarker discovery

OmicScouts is a chemical proteomics company focused on supporting drug and biomarker discovery with its unique expertise and innovative technologies.

Founded by leading proteomics researchers, the company has a track record in delivering significant collaborations with top pharmaceutical and biotechnology companies.

We provide and develop proteome-wide assays that work with native proteins in a physiological setting and enable the identification of small molecule drug targets, target engagement markers, molecular mechanisms of action and drug response biomarkers.

OmicScouts supports your drug and biomarker discovery projects with end-to-end solutions tailored to project specific needs.

Latest News
Feb. 18 - März 28, 2019
Together with the TU Munich, the Science for Life Laboratory at the KTH Royal Institute of Technology in Stockholm and at the Upps...
März 24 - März 28, 2019
We will be present at the the Proteomic Forum 2019 in Potsdam, the Annual meeting of the German Society for Proteome Research. If ...
Mai 13 - Mai 14, 2019
Join us at the the Neuro4D conference in Mainz, Germany. Our CEO, Hannes Hahne, will present work we have done together with our p...

Scientific excellence in proteomics, computational biology and drug discovery

Read More »

Collaborations with leading academic and industry partners

Read More »

Further informations on job openings

Read More »